GSK secures Canadian made high blood pressure drug in US$950 million deal

2026-02-25 - 16:53

GSK PLC agreed to buy 35Pharma Inc., a biotech with an early-stage drug for pulmonary hypertension, as the United Kingdom pharma giant boosts its pipeline of promising experimental therapies. Read More